ABT-418 is a drug developed by Abbott, that has nootropic, neuroprotective and anxiolytic effects, and has been researched for treatment of both Alzheimer's disease and more recently ADHD.
ABT-418 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors. It has nootropic, neuroprotective and anxiolytic effects, and has been researched for treatment of both Alzheimer's disease and more recently ADHD.